Gilinsky N H, Mee A S, Beatty D W, Novis B H, Young G, Price S, Purves L R, Marks I N
Gut. 1985 Sep;26(9):928-34. doi: 10.1136/gut.26.9.928.
Eight patients with diffuse plasma cell infiltration of the small bowel who had the clinical features of immunoproliferative small intestinal disease (IPSID), but whose serum was negative for free alpha-heavy chains, were investigated for evidence of a non-secretory form of alpha-chain disease (alpha-CD). Molecular sieving and immunoblotting of serum, immunoperoxidase staining of biopsy specimens, and in vitro protein synthesis studies utilising an immunoprecipitation technique and polyacrylamide gel electrophoresis, failed to detect any new cases of alpha-CD. Four of the eight cases were found to have diffuse intestinal lymphoma. The remaining four patients, who were unsuccessfully investigated for evidence of a significant abnormality in cellular immunity, have not developed detectable alpha-CD protein or lymphoma over a mean of 143 months. Despite continuing exposure to possible environmental stimuli, it is concluded that not all cases of IPSID elaborate detectable alpha-CD protein or evolve to lymphoma.
对8例小肠弥漫性浆细胞浸润且具有免疫增殖性小肠病(IPSID)临床特征但血清游离α重链阴性的患者进行了研究,以寻找非分泌型α链病(α-CD)的证据。对血清进行分子筛分和免疫印迹、对活检标本进行免疫过氧化物酶染色,以及利用免疫沉淀技术和聚丙烯酰胺凝胶电泳进行体外蛋白质合成研究,均未检测到任何新的α-CD病例。8例中有4例被发现患有弥漫性肠道淋巴瘤。其余4例患者在细胞免疫方面未发现明显异常,在平均143个月的时间里未出现可检测到的α-CD蛋白或淋巴瘤。尽管持续接触可能的环境刺激,但得出的结论是,并非所有IPSID病例都会产生可检测到的α-CD蛋白或发展为淋巴瘤。